Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology
Salvador Bello(Servicio Aragonés de Salud), Antoní Torres(Molina Center for Energy and the Environment), Sergio Fandos(Neumont University), Rosario Menéndez(Hospital Universitari i Politècnic La Fe), Maria Angeles Ruiz(Hospital Universitario Miguel Servet), Francisco De Pablo(Neumont University), Elisa Mincholé(Neumont University), Ana Lasierra(Hospital Universitario Miguel Servet), Elisabeth Vera(Neumont University), Miguel D. Ferrer(Health Research Institute of the Balearic Islands)
Cited by 124
Related Papers
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|European Respiratory Journal|2017|1.4k
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|420
Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
|Current Medicinal Chemistry|2018|242
Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry
|The Lancet Global Health|2019|236
Acute Administration of Inorganic Nitrate Reduces V˙O2peak in Endurance Athletes
|Medicine & Science in Sports & Exercise|2011|137